W. Sandborn

Statistics

Publications

Citations

1.4K

H-Index

Active since

1992

Affiliations

Mayo Clinic(Current)

University of California San Diego

Kitasato University

Inserm

Robarts Clinical Trials

W. Sandborn is an author at Mayo Clinic specializing in inflammatory bowel disease, gastrointestinal inflammation, and inflammatory bowel disease therapy.

Publications per year

1992–2022

Publications

Clinical Pharmacogenetics Implementation Consortium Guidelines for Thiopurine Methyltransferase Genotype and Thiopurine Dosing: 2013 Update

Mary V. Relling, E E Gardner, W. Sandborn et al. · Clinical Pharmacology & Therapeutics · 2013 · 330 citations

Medicine, Genetics, Pharmacology +16

Transdermal Nicotine for Mildly to Moderately Active Ulcerative Colitis

W. Sandborn · Annals of Internal Medicine · 1997 · 262 citations

Pharmacy, Pharmacotherapy, Gastrointestinal Pharmacotherapy +10

Randomised clinical trial: certolizumab pegol for fistulas in Crohn’s disease - subgroup results from a placebo-controlled study

Stefan Schreiber, Ian C. Lawrance, Ole Østergaard Thomsen et al. · Alimentary Pharmacology & Therapeutics · 2010 · 162 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +14

Successful management of Crohn's disease of the ileoanal pouch with infliximab

Elena Ricart, Remo Panaccione, Edward V. Loftus et al. · Gastroenterology · 1999 · 136 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +13

Fecal bile acids, short-chain fatty acids, and bacteria after ileal pouch-anal anastomosis do not differ in patients with pouchitis

W. Sandborn, William J. Tremaine, Kenneth P. Batts et al. · Digestive Diseases and Sciences · 1995 · 81 citations

Medicine, Clinical Sciences, Surgery +11

1–5 of 25